Drug Markets/Tavaborole

Tavaborole

4 NDCs across 4 manufacturers|4 Generic,0 Brand

Tavaborole is used to treat onychomycosis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Jul 7, 2014, and the first generic was approved Oct 13, 2020. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $20 million on Tavaborole across 34,000 claims for 11,000 beneficiaries.

Tavaborole is available as 4 NDCs from 4 manufacturers (4 generic, 0 brand), with NADAC prices from $3.49 to $3.57 per MLa 2% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4

4G / 0B

Manufacturers

4

competing in market

Price Spread

$3.49 – $3.57

per ML

7d Activity

31 flat

avg -2.0% WoW · of 4 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

4 NDCs total, 4 shown

Frequently Asked Questions

What is Tavaborole used to treat?

Tavaborole is used to treat onychomycosis, per the National Library of Medicine's MED-RT classification.

When did Tavaborole become available as a generic?

FDA approved the first generic Tavaborole (ANDA) on Oct 13, 2020. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Tavaborole?

In 2024, Medicare Part D spent $20 million on Tavaborole across 34,000 claims for 11,000 beneficiaries.

How many Tavaborole products are on the market?

The Tavaborole drug market contains 4 NDCs from 4 manufacturers — 4 generic and 0 brand products.

What is the price range for Tavaborole?

NADAC reference prices for Tavaborole range from $3.4902 to $3.5669 per ML — a 2% difference between cheapest and most expensive.

Which manufacturers make Tavaborole?

4 manufacturers list Tavaborole in NADAC. Ranked by number of NDCs, the largest are Cipla USA Inc. (1), Chartwell RX LLC (1), Alembic Pharmaceuticals Inc. (1), Viona Pharmaceuticals Inc. (1).

How has the price of Tavaborole changed recently?

Over the past 7 days, 0 Tavaborole NDCs rose and 3 fell, with a market-wide average change of -2.0%.